Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Why men, wealthy people and maritime residents are more likely to develop skin cancer
A new study led by McGill University, Canada, examines why people living in Atlantic regions…
Common hormone could hold key to treating endometrial cancer
New research from QIMR Berghofer has found that the hormone testosterone may play an important…
Researchers uncover a new type of immunotherapy to treat cancer
Researchers at Peter Mac have identified a new type of immunotherapy in solid tumours that…
Men over 40 with faulty BRCA2 gene should be tested annually for prostate cancer
Michael Porter, University of Central Lancashire Scientists at The Institute of Cancer Research, London, are calling for annual blood tests…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.